NCT05658120View on ClinicalTrials.gov

Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery

CompletedOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

December 13, 2022

Primary Completion Date

December 13, 2022

Study Completion Date

February 18, 2023

Conditions
Postperfusion Syndrome
Interventions
DRUG

noradrenaline/adrenaline

norepinephrine adrenaline in patients with Swan-Ganz catheter monitoring during liver transplantation

Trial Locations (1)

08035

Vall d´Hebron Research Institute VHIR, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER